Lv1
56 积分 2022-11-29 加入
Dealing with KRAS G12C inhibition in non-small cell lung cancer (NSCLC) – biology, clinical results and future directions
15天前
已完结
ALK inhibitors against resistance in non-small cell lung cancer: an 18 year medical arms race
15天前
已完结
ALK rearrangements and resistance mutations in non-small cell lung cancer: molecular mechanisms and therapeutic implications
15天前
已完结
[Oncology Society of Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2026 edition)]
16天前
已完结
Solution of the Structure of the TNF-TNFR2 Complex
1个月前
已完结
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial
2个月前
已完结
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update
2个月前
已关闭
ALK,ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours
2个月前
已完结
Expanded extracolonic tumor spectrum in MUTYH-associated polyposis
2个月前
已完结
Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis
2个月前
已完结
皖公网安备34019202002308
